Oncolytic Virus Immunotherapy Market Trends, Demand & Growth by 2034

Oncolytic Virus Immunotherapy Market Size and Forecasts (2021–2034), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Virus Type (Herpes Simplex Virus, Vaccinia Virus, Adenovirus, Reovirus, Others); Route of Administration (Intratumoral, Intravenous); Application (Melanoma, Non-small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Breast Cancer, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024   |   Base Year: 2025   |   Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00016666
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
Oncolytic Virus Immunotherapy Market Trends, Demand & Growth by 2034
Report Date: Jul 2026   |   Report Code: TIPRE00016666 Email: sales@theinsightpartners.com
Buy Now

The Oncolytic Virus Immunotherapy Market size is expected to reach US$ 2,927.24 Million by 2034 from US$ 465.76 Million in 2025. The market is estimated to record a CAGR of 22.66% from 2026 to 2034.

The report is categorized by Virus Type (Herpes Simplex Virus, Vaccinia Virus, Adenovirus, Reovirus) and further analyzes the market based on Route of Administration (Intratumoral, Intravenous). It also examines the market by Application (Melanoma, Non-small Cell Lung Cancer, Pancreatic Cancer, Breast Cancer).A comprehensive breakdown is provided at global, regional, and country levels for each of these key segments. The report includes market size and forecasts across all segments, presenting values in USD. It also delivers key statistics on the current market status of leading players, along with insights into prevailing market trends and emerging opportunities.

Purpose of the Report

The report Oncolytic Virus Immunotherapy Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Oncolytic Virus Immunotherapy Market Segmentation

Virus Type

  1. Herpes Simplex Virus
  2. Vaccinia Virus
  3. Adenovirus
  4. Reovirus

Route of Administration

  1. Intratumoral
  2. Intravenous

Application

  1. Melanoma
  2. Non-small Cell Lung Cancer
  3. Pancreatic Cancer
  4. Breast Cancer

Market Assessment and Insights

  • Global market for Oncolytic Virus Immunotherapy was valued at US$ 465.76 Million in 2025
  • Annual market size is expected to reach US$ 2,927.24 Million by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 13,325.26 Million
  • Market is anticipated to register a CAGR of 22.66% during the forecast period
  • The United States represents a key market, supported by Harnessing Nature's Power: Oncolytic Viruses Target Cancer Cells, Personalized Treatments: Tailoring Immunotherapy for Every Patient, Innovative Research: Pioneering New Frontiers in Cancer Therapy, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Unlocking Potential: Personalized Oncolytic Virus Therapies for Cancer Patients, Revolutionizing Treatment: Combining Oncolytic Viruses with Immunotherapy, Expanding Access: Affordable Oncolytic Virus Solutions for Emerging Markets are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including Amgen, Inc., Merck KGaA, Shanghai Sunway Biotech Co. Ltd., TILT Biotherapeutics, Oncorus, Inc., Oncolys BioPharma, Inc., Sorrento Therapeutics, Inc., Oncolytics Biotech, Inc., SillaJen, Inc., Replimune Group, while analyzing competitive strategies and innovation developments

Customize This Report To Suit Your Requirement

Get FREE CUSTOMIZATION

Oncolytic Virus Immunotherapy Market: Strategic Insights

oncolytic-virus-immunotherapy-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Oncolytic Virus Immunotherapy Market Growth Drivers

  1. Harnessing Nature's Power: Oncolytic Viruses Target Cancer Cells
  2. Personalized Treatments: Tailoring Immunotherapy for Every Patient
  3. Innovative Research: Pioneering New Frontiers in Cancer Therapy

Oncolytic Virus Immunotherapy Market Future Trends

  1. Oncolytic Virus Therapies Revolutionize Cancer Treatment Landscape
  2. Personalized Oncolytic Treatments Tailored to Individual Tumor Profiles
  3. Rising Investment in Oncolytic Virus Research Fuels Innovative Breakthroughs

Oncolytic Virus Immunotherapy Market Opportunities

  1. Unlocking Potential: Personalized Oncolytic Virus Therapies for Cancer Patients
  2. Revolutionizing Treatment: Combining Oncolytic Viruses with Immunotherapy
  3. Expanding Access: Affordable Oncolytic Virus Solutions for Emerging Markets

Oncolytic Virus Immunotherapy Market Report Scope

Report Attribute Details
Market size in 2025 US$ 465.76 Million
Market Size by 2034 US$ 2,927.24 Million
Global CAGR (2026 - 2034) 22.66%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Virus Type
  • Herpes Simplex Virus
  • Vaccinia Virus
  • Adenovirus
  • Reovirus
By Route of Administration
  • Intratumoral
  • Intravenous
By Application
  • Melanoma
  • Non-small Cell Lung Cancer
  • Pancreatic Cancer
  • Breast Cancer
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen, Inc.
  • Merck KGaA
  • Shanghai Sunway Biotech Co. Ltd.
  • TILT Biotherapeutics
  • Oncorus, Inc.
  • Oncolys BioPharma, Inc.
  • Sorrento Therapeutics, Inc.
  • Oncolytics Biotech, Inc.
  • SillaJen, Inc.
  • Replimune Group

Oncolytic Virus Immunotherapy Market Players Density: Understanding Its Impact on Business Dynamics

The Oncolytic Virus Immunotherapy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

oncolytic-virus-immunotherapy-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Oncolytic Virus Immunotherapy Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Oncolytic Virus Immunotherapy Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
☀️ Eligible for Summer Discount
Unlock Exclusive Report Discounts
Enquire Now
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA
Page Updated: Apr 2026